Different State Regulatory Approaches Reflect Open Questions About AI Mental Health Tools — The Monitor

States are taking different regulatory approaches to AI mental health tools in response to concerns about chatbots providing inaccurate or potentially dangerous advice. Laws and pending legislation in some states restrict AI from providing or advertising itself as therapy, while others focus on data protections, disclosures, and patient consent requirements.

Read More

Listen to the Latest ‘KFF Health News Minute’

The KFF Health News Minute is available every Thursday via direct download or the RSS feed. Aug. 27 Katheryn Houghton [CATH-er-in HOW-tun] reads the week’s news: A wristband with the words “I Gave Birth” could be a lifesaving tool for new moms, and many homeless people will have to prove they’re working to stay on Medicaid. Your browser does not support the audio element. Can’t see the audio player?…

Read More

Revolution Medicines Receives Landmark FDA Drug Approval in Pancreatic Cancer

FDA approval of Revolution Medicines’ daraxonrasib, brand name Rasonque, makes the molecule the first RAS inhibitor approved for treating pancreatic adenocarcinoma, the most common type of pancreatic cancer. The speedy regulatory nod specifically covers advanced cases of this type of cancer, which has had limited treatment options. The post Revolution Medicines Receives Landmark FDA Drug…

Read More